Potential role of the geriatric nutritional risk index as a novel risk factor for the development of non-valvular atrial fibrillation in patients with heart failure

被引:1
|
作者
Kaplan, M. [1 ]
Vuruskan, E. [1 ]
Altunbas, G. [1 ]
Yavuz, F. [2 ]
Kaplan, G., I [3 ]
Duzen, I., V [1 ]
Alic, E. [1 ]
Savcilioglu, M. D. [1 ]
Annac, S. [4 ]
Bursa, N. [5 ]
Sucu, N. M. [1 ]
机构
[1] Gaziantep Univ, Dept Cardiol, Sch Med, TR-27100 Gaziantep, Turkey
[2] Adiyaman Univ, Dept Cardiol, Sch Med, Adana, Turkey
[3] Ersin Arslan Training & Res Hosp, Dept Internal Med, Gaziantep, Turkey
[4] Hasan Kalyoncu Univ, Fac Hlth Sci, Gaziantep, Turkey
[5] Hacettepe Univ, Dept Stat, Ankara, Turkey
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2021年 / 122卷 / 09期
关键词
malnutrition; heart failure; atrial fibrillation; OBESITY PARADOX; OUTCOMES; MORTALITY;
D O I
10.4149/BLL_2021_102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: The geriatric nutritional risk index (GNRI) is a simple and objective nutritional assessment tool for elderly patients. Lower GNRI values are associated with a worse prognosis in heart failure with reduced ejection fraction (HFrEF). Our aim is to investigate the relationship between malnutrition and follow-up cardiovascular (CV) events in HFrEF. METHODS: A retrospective study was performed on 362 patients with HFrEF. The baseline GNRI was calculated at the first visit. The patients were divided into three groups according to the GNRI: >98, no-risk group; 92 to <= 98, low risk group; 82 to <92, moderate-to-high-risk group. The study endpoint was a composite of follow-up CV events, including all-cause mortality, non-valvular atrial fibrillation (NVAF) , need for cardioverter defibrillator (ICD) therapy, HfrEF-related hospitalizations and need for percutaneous coronary interventions (PCIs). RESULTS: Follow-up data showed that the group with moderate-to-high risk had a significantly higher incidence of NVAF, PCIs and all-cause mortality compared to other groups (p<0.001, p: 0.026 and p<0.001 respectively). However, hospitalizations and the need for ICD placement were similar as compared between groups (p>0.05). Mean GNRI value was 83.3 in NVAF patients and 101.1 in patients without NVAF (p<0.001). Kaplan Meier survival analysis showed that patients from the group with moderate-to-high risk had a significantly worse survival rate (p < 0.001). In the multivariate Cox regression analysis, the group with moderate-to-high risk (HR =3.872) and ICD implantations (HR = 4.045) were associated with increased mortality. CONCLUSION: The GNRI value may have a potential role for predicting future events, especially NVAF in patients with HfrEF.
引用
收藏
页码:636 / 642
页数:7
相关论文
共 50 条
  • [21] Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure
    Martinez, Brandon K.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Sood, Nitesh A.
    Coleman, Craig I.
    ESC HEART FAILURE, 2019, 6 (01): : 10 - 15
  • [22] Heart Failure and the Non-Resolution of Atrial Thrombus Detected in Anticoagulated Patients with Non-Valvular Atrial Fibrillation
    Yang, Shu
    Yang, Jie
    Chen, Ning
    Cui, Chang
    Jiao, Jincheng
    Zhu, Li
    Li, Mingfang
    Chen, Minglong
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2025, 31
  • [23] The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation
    Van den Ham, H. A.
    Klungel, O. H.
    Leufkens, H. G. M.
    Van Staa, T. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) : 107 - 115
  • [24] Effect of congestive heart failure on safety and efficacy of left atrial appendage closure in patients with non-valvular atrial fibrillation
    Zhao, Mingzhong
    Hou, Cody R.
    Bai, Jianlin
    Post, Felix
    Walsleben, Jens
    Herold, Nora
    Yu, Juan
    Zhang, Zufeng
    Yu, Jiangtao
    EXPERT REVIEW OF MEDICAL DEVICES, 2022, 19 (10) : 805 - 814
  • [25] A novel risk score for predicting left atrial and left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation
    Fu, Yuan
    Li, Kuibao
    Gao, Yuanfeng
    Wang, Lefeng
    Chen, Mulei
    Yang, Xinchun
    THROMBOSIS RESEARCH, 2020, 192 : 161 - 166
  • [26] Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation
    Dzeshka, Mikhail S.
    Lip, Gregory Y. H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (17) : 2661 - 2678
  • [27] Modification of the left atrial appendage and its role in stroke risk reduction with non-valvular atrial fibrillation
    Rashid, Hashrul N.
    Layland, Jamie
    IJC HEART & VASCULATURE, 2021, 32
  • [28] Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation have a Risk for Aortogenic Embolizations
    Kojima, Keisuke
    Fukamachi, Daisuke
    Okumura, Yasuo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (07) : 786 - 788
  • [29] Geriatric Nutritional Risk Index Predict Cardiovascular Events in Patients at Risk for Heart Failure
    Minamisawa, Masatoshi
    Miura, Takashi
    Motoki, Hirohiko
    Ueki, Yasushi
    Mochidome, Tomoaki
    Oguchi, Yasutaka
    Nishimura, Hitoshi
    Ebisawa, Soichiro
    Koyama, Jun
    Ikeda, Uichi
    CIRCULATION, 2016, 134
  • [30] Impact of Body Mass Index on the Prognosis of Japanese Patients With Non-Valvular Atrial Fibrillation
    Inoue, Hiroshi
    Kodani, Eitaro
    Atarashi, Hirotsugu
    Okumura, Ken
    Yamashita, Takeshi
    Origasa, Hideki
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (02) : 215 - 221